Type 1 diabetes and Joint swelling

Summary:

Joint swelling is found among people with Type 1 diabetes, especially for people who are female, 60+ old.

The study analyzes which people have Joint swelling with Type 1 diabetes. It is created by eHealthMe based on reports of 76 people who have Type 1 diabetes from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

What is Joint swelling?

Joint swelling is found to be associated with 2,120 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Joint swelling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

76 people who have Type 1 Diabetes and Joint Swelling are studied.

Would you have Joint swelling when you have Type 1 diabetes?

Gender of people who have Type 1 Diabetes and experienced Joint Swelling *:

  • female: 70.27 %
  • male: 29.73 %

Age of people who have Type 1 Diabetes and experienced Joint Swelling *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.08 %
  • 20-29: 2.04 %
  • 30-39: 8.16 %
  • 40-49: 20.41 %
  • 50-59: 24.49 %
  • 60+: 40.82 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 15.79%
  2. High Blood Cholesterol: 11 people, 14.47%
  3. Diabetes: 8 people, 10.53%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 9.21%
  5. High Blood Pressure: 6 people, 7.89%
  6. Neuropathy Peripheral (surface nerve damage): 4 people, 5.26%
  7. Hypersensitivity: 4 people, 5.26%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.95%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 3.95%
  10. Depression: 3 people, 3.95%

Common drugs taken by these people *:

  1. Humalog: 20 people, 26.32%
  2. Lantus: 17 people, 22.37%
  3. Novolog: 15 people, 19.74%
  4. Humira: 12 people, 15.79%
  5. Levemir: 11 people, 14.47%
  6. Novorapid: 6 people, 7.89%
  7. Metformin: 6 people, 7.89%
  8. Methotrexate: 6 people, 7.89%
  9. Folic Acid: 5 people, 6.58%
  10. Lisinopril: 5 people, 6.58%

Common symptoms for these people *:

  1. Joint Pain: 22 people, 28.95%
  2. Peripheral Swelling: 19 people, 25.00%
  3. Blood Glucose Increased: 16 people, 21.05%
  4. Weight Increased: 12 people, 15.79%
  5. Drug Ineffective: 9 people, 11.84%
  6. Fatigue (feeling of tiredness): 9 people, 11.84%
  7. Pain: 8 people, 10.53%
  8. Pain In Extremity: 8 people, 10.53%
  9. Gait Disturbance: 8 people, 10.53%
  10. Abdominal Distension: 8 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Joint swelling?

- Check whether Joint swelling is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Joint swelling:

All the conditions that are associated with Joint swelling:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Joint swelling and Type 1 diabetes, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: